Brigitte Dréno
Impact in
- Dermatology top 0.01%
- Acne and Rosacea Treatments and Effects
- Cutaneous lymphoproliferative disorders research
- Dermatology and Skin Diseases
- Oncology top 0.05%
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
Papers in
- Dermatology 385
- Acne and Rosacea Treatments and Effects 226
- Cutaneous lymphoproliferative disorders research 62
- Dermatologic Treatments and Research 38
- Oncology 207
- Cutaneous Melanoma Detection and Management 118
- Cancer Immunotherapy and Biomarkers 82
- Co-authors
- Amir Khammari (185 shared papers)Florence Poli (26 shared papers)Gaelle Quereux (121 shared papers)Jean‐Michel Nguyen (86 shared papers)Stéphane Corvec (30 shared papers)Anne‐Chantal Knol (66 shared papers)Harald P. M. Gollnick (17 shared papers)James Larkin (20 shared papers)
- Journals
- Journal of the European Academy of Dermatology and Venereology (106 papers)European Journal of Dermatology (51 papers)British Journal of Dermatology (37 papers)Acta Dermato Venereologica (32 papers)Dermatology (25 papers)
- Partner nations
- FranceGermanyUnited States
In The Last Decade
Brigitte Dréno
781 papers receiving 50.5k citations
Brigitte Dréno's Hit Papers
Peers
Comparison fields: 5 of 186
- Dermatology 12.9k
- Oncology 16.6k
- Immunology 3.7k
- Molecular Biology 10.2k
- Cancer Research 1.7k
Countries citing papers authored by Brigitte Dréno
This map shows the geographic impact of Brigitte Dréno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brigitte Dréno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brigitte Dréno more than expected).
Fields of papers citing papers by Brigitte Dréno
This network shows the impact of papers produced by Brigitte Dréno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brigitte Dréno. The network helps show where Brigitte Dréno may publish in the future.
Co-authors
The 25 scholars most cited alongside Brigitte Dréno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 834 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma Hit paper breakdown → | 2015 | 6953 |
| 2 | Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation Hit paper breakdown → | 2011 | 6392 |
| 3 | Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma Hit paper breakdown → | 2012 | 1821 |
| 4 | Combined Vemurafenib and Cobimetinib in BRAF -Mutated Melanoma Hit paper breakdown → | 2014 | 1710 |
| 5 | Improved survival with MEK Inhibition in BRAF-mutated melanoma for the METRIC Study Group Hit paper breakdown → | 2012 | 1224 |
| 6 | Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma Hit paper breakdown → | 2000 | 1029 |
| 7 | Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study Hit paper breakdown → | 2014 | 839 |
| 8 | Cobimetinib combined with vemurafenib in advanced BRAFV600-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial Hit paper breakdown → | 2016 | 829 |
| 9 | Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma Hit paper breakdown → | 2013 | 673 |
| 10 | Management of Acne Hit paper breakdown → | 2003 | 655 |
| 11 | New insights into the management of acne: An update from the Global Alliance to Improve Outcomes in Acne Group Hit paper breakdown → | 2009 | 641 |
| 12 | Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens Hit paper breakdown → | 1998 | 612 |
| 13 | Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial Hit paper breakdown → | 2018 | 518 |
| 14 | 2002 | 484 | |
| 15 | 2016 | 481 | |
| 16 | Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial Hit paper breakdown → | 2017 | 455 |
| 17 | 2002 | 441 | |
| 18 | Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates Hit paper breakdown → | 2018 | 439 |
| 19 | 2017 | 423 | |
| 20 | 2007 | 377 |
About Brigitte Dréno
Brigitte Dréno is a scholar working on Dermatology, Oncology, Immunology, Epidemiology and Molecular Biology, having authored 834 papers that have together received 52.8k indexed citations. Recurring topics across this work include Acne and Rosacea Treatments and Effects (226 papers), Cutaneous Melanoma Detection and Management (118 papers), Cancer Immunotherapy and Biomarkers (82 papers), Cutaneous lymphoproliferative disorders research (62 papers), Immunotherapy and Immune Responses (59 papers), Melanoma and MAPK Pathways (53 papers), Nonmelanoma Skin Cancer Studies (48 papers) and Dermatologic Treatments and Research (38 papers). The work is most often cited by research in Dermatology (12.9k citations), Oncology (16.6k citations), Immunology (3.7k citations), Molecular Biology (10.2k citations) and Cancer Research (1.7k citations). Brigitte Dréno has collaborated with scholars based in France, Germany and United States. Frequent co-authors include Amir Khammari, Florence Poli, Gaelle Quereux, Jean‐Michel Nguyen, Stéphane Corvec, Anne‐Chantal Knol, Harald P. M. Gollnick, James Larkin, Claus Garbe and Jean‐Jacques Grob. Their work appears in journals such as Journal of the European Academy of Dermatology and Venereology, European Journal of Dermatology, British Journal of Dermatology, Acta Dermato Venereologica and Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.